Russell Investments Group’s Epizyme, Inc EPZM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-8,900
| Closed | -$13K | – | 3026 |
|
|
2022
Q2 | $13K | Hold |
8,900
| – | – | ﹤0.01% | 2838 |
|
|
2022
Q1 | $10K | Sell |
8,900
-77,039
| -90% | -$126K | ﹤0.01% | 2711 |
|
|
2021
Q4 | $213K | Buy |
85,939
+77,039
| +866% | +$303K | ﹤0.01% | 2704 |
|
|
2021
Q3 | $45K | Sell |
8,900
-64,443
| -88% | -$391K | ﹤0.01% | 2953 |
|
|
2021
Q2 | $608K | Sell |
73,343
-80,796
| -52% | -$681K | ﹤0.01% | 2512 |
|
|
2021
Q1 | $1.34M | Buy |
154,139
+79,419
| +106% | +$822K | ﹤0.01% | 2109 |
|
|
2020
Q4 | $812K | Sell |
74,720
-5,375
| -7% | -$66.3K | ﹤0.01% | 2214 |
|
|
2020
Q3 | $955K | Hold |
80,095
| – | – | ﹤0.01% | 2086 |
|
|
2020
Q2 | $1.28M | Sell |
80,095
-121
| -0.2% | -$2.11K | ﹤0.01% | 1903 |
|
|
2020
Q1 | $1.24M | Buy |
80,216
+35,624
| +80% | +$765K | ﹤0.01% | 1740 |
|
|
2019
Q4 | $1.1M | Buy |
+44,592
| New | +$662K | ﹤0.01% | 2054 |
|
|
2019
Q1 | – | Sell |
-7,800
| Closed | -$48K | – | 3056 |
|
|
2018
Q4 | $48K | Buy |
7,800
+2,600
| +50% | +$19.9K | ﹤0.01% | 2802 |
|
|
2018
Q3 | $55K | Buy |
+5,200
| New | +$59.4K | ﹤0.01% | 2822 |
|
|
2018
Q1 | – | Sell |
-37,578
| Closed | -$489K | – | 3034 |
|
|
2017
Q4 | $489K | Hold |
37,578
| – | – | ﹤0.01% | 2441 |
|
|
2017
Q3 | $716K | Sell |
37,578
-2,012
| -5% | -$30.7K | ﹤0.01% | 2305 |
|
|
2017
Q2 | $597K | Sell |
39,590
-5,753
| -13% | -$87K | ﹤0.01% | 2344 |
|
|
2017
Q1 | $778K | Buy |
45,343
+16,924
| +60% | +$225K | ﹤0.01% | 2233 |
|
|
2016
Q4 | $351K | Buy |
+28,419
| New | +$297K | ﹤0.01% | 2569 |
|
Other funds holding EPZM
Russell Investments Group's EPZM Position: Q3 2022 in Review
Russell Investments Group sold out of Epizyme, Inc (EPZM) in Q3 2022, closing a stake of 8,900 shares — an estimated $13K sold.
Russell Investments Group first reported a position in EPZM in Q4 2016 and held it in 18 quarters. The position peaked at $1.34M in Q1 2021. 0 funds tracked by Wall St. Rank hold EPZM as of Q3 2022.
- Russell Investments Group reported no remaining Epizyme, Inc position as of Q3 2022 after selling out during the quarter.
- Russell Investments Group sold 8,900 Epizyme, Inc shares in Q3 2022, an estimated $13K.
- Russell Investments Group first reported a position in Epizyme, Inc in Q4 2016 and held it in 18 quarters.
- Russell Investments Group's Epizyme, Inc position peaked at $1.34M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2022.
Based on Russell Investments Group's 13F filing for Q3 2022, filed 4 Nov 2022.